162 related articles for article (PubMed ID: 38074116)
1. Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines.
Casotti C; Hattinger CM; Patrizio MP; Luppi S; Fantoni L; Pasello M; Scotlandi K; Ibrahim T; Serra M
Front Pharmacol; 2023; 14():1294873. PubMed ID: 38074116
[No Abstract] [Full Text] [Related]
2. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
Hattinger CM; Casotti C; Patrizio MP; Luppi S; Fantoni L; Scotlandi K; Ibrahim T; Serra M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233089
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines.
Hattinger CM; Stoico G; Michelacci F; Pasello M; Scionti I; Remondini D; Castellani GC; Fanelli M; Scotlandi K; Picci P; Serra M
Genes Chromosomes Cancer; 2009 Apr; 48(4):289-309. PubMed ID: 19105235
[TBL] [Abstract][Full Text] [Related]
4. Analysis of dihydrofolate reductase and reduced folate carrier gene status in relation to methotrexate resistance in osteosarcoma cells.
Serra M; Reverter-Branchat G; Maurici D; Benini S; Shen JN; Chano T; Hattinger CM; Manara MC; Pasello M; Scotlandi K; Picci P
Ann Oncol; 2004 Jan; 15(1):151-60. PubMed ID: 14679136
[TBL] [Abstract][Full Text] [Related]
5. Genomic imbalances associated with methotrexate resistance in human osteosarcoma cell lines detected by comparative genomic hybridization-based techniques.
Hattinger CM; Reverter-Branchat G; Remondini D; Castellani GC; Benini S; Pasello M; Manara MC; Scotlandi K; Picci P; Serra M
Eur J Cell Biol; 2003 Sep; 82(9):483-93. PubMed ID: 14582536
[TBL] [Abstract][Full Text] [Related]
6. Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate.
Jabeen S; Holmboe L; Alnæs GI; Andersen AM; Hall KS; Kristensen VN
Pharmacogenomics J; 2015 Oct; 15(5):385-90. PubMed ID: 25778468
[TBL] [Abstract][Full Text] [Related]
7. Influence of reduced folate carrier and dihydrofolate reductase genes on methotrexate-induced cytotoxicity.
Yoon SA; Choi JR; Kim JO; Shin JY; Zhang X; Kang JH
Cancer Res Treat; 2010 Sep; 42(3):163-71. PubMed ID: 20948922
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate.
Cwiklinska M; Czogala M; Kwiecinska K; Madetko-Talowska A; Szafarz M; Pawinska K; Wieczorek A; Klekawka T; Rej M; Stepien K; Halubiec P; Lazarczyk A; Miklusiak K; Bik-Multanowski M; Balwierz W; Skoczen S
Front Pediatr; 2020; 8():307. PubMed ID: 32612964
[No Abstract] [Full Text] [Related]
9. Contribution of genetic polymorphism of methylene tetrahydrofolate reductase on the effect of methotrexate in ectopic pregnancy patients.
Deng J; Chen L; Xue H; Zeng FX; Niu PG; Shi DH
J Clin Lab Anal; 2020 Jan; 34(1):e23030. PubMed ID: 31502727
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the expression pattern of MTHFR, DHFR, TYMS, and SLC19A1 genes after treatment of laryngeal cancer cells with high and low doses of methotrexate.
Galbiatti AL; Castro R; Caldas HC; Padovani JA; Pavarino EC; Goloni-Bertollo EM
Tumour Biol; 2013 Dec; 34(6):3765-71. PubMed ID: 23838799
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia.
Zgheib NK; Akra-Ismail M; Aridi C; Mahfouz R; Abboud MR; Solh H; Muwakkit SA
Pharmacogenet Genomics; 2014 Aug; 24(8):387-96. PubMed ID: 25007187
[TBL] [Abstract][Full Text] [Related]
13. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
Yin JQ; Shen JN; Su WW; Wang J; Huang G; Jin S; Guo QC; Zou CY; Li HM; Li FB
Acta Pharmacol Sin; 2007 May; 28(5):712-20. PubMed ID: 17439728
[TBL] [Abstract][Full Text] [Related]
14. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.
Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V
Toxicol Sci; 2014 Nov; 142(1):196-209. PubMed ID: 25124723
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.
Wessels JA; de Vries-Bouwstra JK; Heijmans BT; Slagboom PE; Goekoop-Ruiterman YP; Allaart CF; Kerstens PJ; van Zeben D; Breedveld FC; Dijkmans BA; Huizinga TW; Guchelaar HJ
Arthritis Rheum; 2006 Apr; 54(4):1087-95. PubMed ID: 16572443
[TBL] [Abstract][Full Text] [Related]
16. Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma.
Park JA; Shin HY
Blood Res; 2016 Mar; 51(1):50-7. PubMed ID: 27104192
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.
Plaza-Plaza JC; Aguilera M; Cañadas-Garre M; Chemello C; González-Utrilla A; Faus Dader MJ; Calleja MA
OMICS; 2012 Nov; 16(11):589-95. PubMed ID: 23095111
[TBL] [Abstract][Full Text] [Related]
18. Reduced folate carrier gene (RFC1) expression and anti-folate resistance in transfected and non-selected cell lines.
Moscow JA; Connolly T; Myers TG; Cheng CC; Paull K; Cowan KH
Int J Cancer; 1997 Jul; 72(1):184-90. PubMed ID: 9212241
[TBL] [Abstract][Full Text] [Related]
19. Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity.
Sala-Icardo L; Lamana A; Ortiz AM; García Lorenzo E; Moreno Fresneda P; García-Vicuña R; González-Álvaro I
Reumatol Clin; 2017; 13(6):318-325. PubMed ID: 27751863
[TBL] [Abstract][Full Text] [Related]
20. Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis.
Chandran V; Siannis F; Rahman P; Pellett FJ; Farewell VT; Gladman DD
J Rheumatol; 2010 Jul; 37(7):1508-12. PubMed ID: 20472929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]